The Allen Institute is launching a $400 million initiative, the Brain Health Accelerator, to develop gene therapies for neurodegenerative diseases including Alzheimer's, Parkinson's, Huntington's, and ALS. It marks the first time the Seattle research organization, founded by Paul Allen in 2003, has
โก
Key Insights
10 editorial insights.
AiFeed24 Teamยทโฑ 1 min readยทNews
Deep Analysis
Multi-Source Intelligence
Found this useful? Share it!
Related Stories

Jedify raises $24M to give enterprise AI agents the business context they lack

Zscaler unveils ZAgent Framework to automate zero-trust SASE operations

Exclusive: Relai raises $6.9M to enable verifiable and continuous learning for AI agents

